Crossmark

Valoración de la transición de vedolizumab intravenoso a subcutáneo en pacientes con enfermedad inflamatoria intestinal

Crossref DOI link: https://doi.org/10.1016/j.gastrohep.2024.502201

Published Print: 2025-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Amor Costa, Carmen

Suárez Ferrer, Cristina

García Ramírez, Laura

Martín-Arranz, Eduardo

Poza Cordón, Joaquín

Rueda García, José Luis

Sánchez Azofra, María

González Diaz, Irene

Amiama Roig, Clara

Martín-Arranz, María Dolores
License Information

Text and Data Mining valid from 2025-03-01

Text and Data Mining valid from 2025-03-01

stm-asf valid from 2025-03-01

stm-asf valid from 2025-03-01

stm-asf valid from 2025-03-01

stm-asf valid from 2025-03-01

stm-asf valid from 2025-03-01
More Information

This article is maintained by: Elsevier

Article Title: Valoración de la transición de vedolizumab intravenoso a subcutáneo en pacientes con enfermedad inflamatoria intestinal

Journal Title: Gastroenterología y Hepatología

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.gastrohep.2024.502201

Content Type: article

Copyright: © 2024 Elsevier España, S.L.U. All rights reserved.